Advances in spinal muscular atrophy therapeutics-Reference-Cited by-同舟云学术

Advances in spinal muscular atrophy therapeutics

Published:2018-01 Issue: Volume:11 Page:175628561875450
ISSN:1756-2864
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Parente Valeria¹,Corti Stefania²

Affiliation:

1. Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

2. Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756285618754501

Reference42 articles.

1. Spinal Muscular Atrophy

2. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

3. Identification and characterization of a spinal muscular atrophy-determining gene

4. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

5. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of inpatient and emergency department healthcare resource utilization and costs pre- and post-nusinersen for the treatment of spinal muscular atrophy using United States claims;Journal of Comparative Effectiveness Research;2024-07

2. A CONTRIBUIÇÃO DA FISIOTERAPIA NO TRATAMENTO DA ATROFIA MUSCULAR ESPINHAL (AME): REVISÃO INTEGRATIVA;Revista Multidisciplinar do Nordeste Mineiro;2024-06-04

3. Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide;Biomedicine & Pharmacotherapy;2024-06

4. Newborn Screening for Neuromuscular Disorders, Disorders of Glycogen Metabolism, and Fatty Acid Oxidation;OBM Genetics;2024-04-18

5. Lafora Disease: A Case Report and Evolving Treatment Advancements;Brain Sciences;2023-12-06